OSIR News and Press, Osiris Therapeutics Inc. From 03/22/19

I have been researching Osiris Therapeutics (NASDAQ: OSIR) for several years. Last year I began summarizing my perspective in articles on Seeking Alpha. My most recent blog post was September 2018. I did this to fill the void left by a lack of public analyst coverage. While I have been the...

In the long run, it's not just how much money you make that will determine your future prosperity. It's how much of that money you put to work by saving it and investing it. - Peter Lynch (stellar value and growth investor) On March 12, 2019, Osiris Therapeutics ( OSIR ) disclosed that S...

Smith & Nephew ( SNN ) , which is often named as a key acquisition target, actually made quite a nice bolt-on deal itself as it is acquiring Osiris Therapeutics ( OSIR ) in a $660 million deal. The deal is somewhat surprising as the company only recently was reportedly interested in N...

SALT LAKE CITY, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that Jay M. Moyes has been named...

Editor's note: Seeking Alpha is proud to welcome Diligence Wound Care Global LLC as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more &#x...

COLUMBIA, Md., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, is pleased to announce that its Board of Directors appointed Samson Tom, ...

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of iPic Entertainment Inc. (NASDAQ:IPIC), Smith Micro Software, Inc. (NAS...

Osiris Therapeutics (NASDAQ: OSIR ): Q3 GAAP EPS of $0.11. More news on: Osiris Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

COLUMBIA, Md., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, today reported its results for the third quarter ending September 30, 201...

COLUMBIA, Md., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, will present advanced clinical and scientific research at the Symposium o...